As the world leader in in vitro allergy diagnostics, we offer everything from direct point-of-care tests to exact measurement of specific IgE antibody blood levels, as well as other important allergy risk markers. ImmunoCAP is one of the most important tools for fully understanding allergy, helping clinicians make sense of symptoms such as rhinitis, eczema, wheezing and asthma.
EliA blood tests, for efficient autoimmunity testing, are a tool that can have major impact on a doctor’s diagnostic decision, thereby making a difference in patient care. We use advanced techniques such as recombinant gene technology to develop the latest in standardized, reliable and high-quality blood tests for the detection of disease-specific autoantibodies.
Delivering our products to a global market can sometimes be as challenging as manufacturing them. That is because we are dedicated to providing testing products that work as well in the real world as they do in our quality control laboratory.
To that end, we continually upgrade our sophisticated production and distribution system to manage the timely worldwide delivery of perishable test kits. And of course, we take into account regional differences and unpredictable pollen seasons around the world.
Another way we strive for excellence is by working with quality-conscious laboratory staff in more than 50 countries to help identify areas for improvement. Moreover, we regularly exchange vital reference information via our Quality Club initiative, a unique forum for voluntary cooperation between more than 800 leading clinical laboratories around the world.